EdgarLookup

Mission Produce, Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Mission Produce, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
2.7%
Profit Margin
Net income ÷ revenue
3.8%
Return on Assets
Net income ÷ assets
0.62x
Debt-to-Equity
Total liabilities ÷ equity
+12.7%
Revenue Growth
Year over year

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Oct 31, 2025 $1.39B Dec 18, 2025
FY2025 Oct 31, 2024 $1.23B Dec 18, 2025
FY2025 Oct 31, 2023 $953.90M Dec 18, 2025
FY2024 Oct 31, 2022 $1.05B Dec 19, 2024
FY2023 Oct 31, 2021 $891.70M Dec 21, 2023
FY2022 Oct 31, 2020 $862.30M Dec 22, 2022
FY2021 Oct 31, 2019 $883.30M Dec 22, 2021

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2025 Oct 31, 2025 $160.70M Dec 18, 2025
FY2025 Oct 31, 2024 $152.50M Dec 18, 2025
FY2025 Oct 31, 2023 $83.30M Dec 18, 2025
FY2024 Oct 31, 2022 $89.80M Dec 19, 2024
FY2023 Oct 31, 2021 $124.50M Dec 21, 2023
FY2022 Oct 31, 2020 $124.60M Dec 22, 2022
FY2021 Oct 31, 2019 $154.70M Dec 22, 2021

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Oct 31, 2025 $37.70M Dec 18, 2025
FY2025 Oct 31, 2024 $36.70M Dec 18, 2025
FY2025 Oct 31, 2023 ($2.80M) Dec 18, 2025
FY2024 Oct 31, 2022 ($34.60M) Dec 19, 2024
FY2023 Oct 31, 2021 $44.90M Dec 21, 2023
FY2022 Oct 31, 2020 $28.80M Dec 22, 2022
FY2021 Oct 31, 2019 $71.70M Dec 22, 2021

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Oct 31, 2025 $65.20M Dec 18, 2025
FY2025 Oct 31, 2024 $65.70M Dec 18, 2025
FY2025 Oct 31, 2023 $6.90M Dec 18, 2025
FY2024 Oct 31, 2022 ($37.20M) Dec 19, 2024
FY2023 Oct 31, 2021 $60.90M Dec 21, 2023
FY2022 Oct 31, 2020 $68.40M Dec 22, 2022
FY2021 Oct 31, 2019 $106.50M Dec 22, 2021

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Oct 31, 2025 $95.50M Dec 18, 2025
FY2025 Oct 31, 2024 $86.80M Dec 18, 2025
FY2025 Oct 31, 2023 $76.40M Dec 18, 2025
FY2024 Oct 31, 2022 $77.50M Dec 19, 2024
FY2023 Oct 31, 2021 $63.60M Dec 21, 2023
FY2022 Oct 31, 2020 $56.20M Dec 22, 2022
FY2021 Oct 31, 2019 $48.20M Dec 22, 2021

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Oct 31, 2025 $88.60M Dec 18, 2025
FY2025 Oct 31, 2024 $93.40M Dec 18, 2025
FY2025 Oct 31, 2023 $29.20M Dec 18, 2025
FY2024 Oct 31, 2022 $35.20M Dec 19, 2024
FY2023 Oct 31, 2021 $47.00M Dec 21, 2023
FY2022 Oct 31, 2020 $78.90M Dec 22, 2022
FY2021 Oct 31, 2019 $92.60M Dec 22, 2021

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Oct 31, 2025 $51.40M Dec 18, 2025
FY2025 Oct 31, 2024 $32.20M Dec 18, 2025
FY2025 Oct 31, 2023 $49.80M Dec 18, 2025
FY2024 Oct 31, 2022 $61.20M Dec 19, 2024
FY2023 Oct 31, 2021 $73.40M Dec 21, 2023
FY2022 Oct 31, 2020 $67.30M Dec 22, 2022
FY2021 Oct 31, 2019 $29.70M Dec 22, 2021

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Oct 31, 2025 $983.00M Dec 18, 2025
FY2025 Oct 31, 2024 $971.50M Dec 18, 2025
FY2024 Oct 31, 2023 $914.80M Dec 19, 2024
FY2023 Oct 31, 2022 $879.50M Dec 21, 2023
FY2022 Oct 31, 2021 $873.50M Dec 22, 2022
FY2021 Oct 31, 2020 $777.30M Dec 22, 2021

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Oct 31, 2025 $363.10M Dec 18, 2025
FY2025 Oct 31, 2024 $394.40M Dec 18, 2025
FY2024 Oct 31, 2023 $386.50M Dec 19, 2024
FY2023 Oct 31, 2022 $356.60M Dec 21, 2023
FY2022 Oct 31, 2021 $339.30M Dec 22, 2022
FY2021 Oct 31, 2020 $303.80M Dec 22, 2021

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Oct 31, 2025 $587.30M Dec 18, 2025
FY2025 Oct 31, 2024 $547.30M Dec 18, 2025
FY2024 Oct 31, 2023 $503.60M Dec 19, 2024
FY2023 Oct 31, 2022 $502.10M Dec 21, 2023
FY2022 Oct 31, 2021 $534.20M Dec 22, 2022
FY2021 Oct 31, 2020 $473.50M Dec 22, 2021
FY2022 Oct 31, 2019 $379.00M Dec 22, 2022
FY2021 Oct 31, 2018 $313.50M Dec 22, 2021

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Oct 31, 2025 $39.40M Dec 18, 2025
FY2025 Oct 31, 2024 $39.40M Dec 18, 2025
FY2024 Oct 31, 2023 $39.40M Dec 19, 2024
FY2024 Oct 31, 2022 $39.40M Dec 19, 2024
FY2022 May 1, 2022 $12.50M Dec 22, 2022
FY2023 Oct 31, 2021 $76.40M Dec 21, 2023
FY2021 Oct 31, 2020 $76.40M Dec 22, 2021

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Oct 31, 2025 $339.30M Dec 18, 2025
FY2025 Oct 31, 2024 $307.70M Dec 18, 2025
FY2024 Oct 31, 2023 $271.00M Dec 19, 2024
FY2023 Oct 31, 2022 $274.40M Dec 21, 2023
FY2022 Oct 31, 2021 $309.00M Dec 22, 2022
FY2021 Oct 31, 2020 $251.20M Dec 22, 2021

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Oct 31, 2025 $64.80M Dec 18, 2025
FY2025 Oct 31, 2024 $58.00M Dec 18, 2025
FY2025 Oct 31, 2023 $42.90M Dec 18, 2025
FY2024 Oct 31, 2022 $52.80M Dec 19, 2024
FY2023 Oct 31, 2021 $84.50M Dec 21, 2023
FY2022 Oct 31, 2020 $124.00M Dec 22, 2022
FY2021 Oct 31, 2019 $64.00M Dec 22, 2021

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Oct 31, 2025 $95.80M Dec 18, 2025
FY2025 Oct 31, 2024 $113.70M Dec 18, 2025
FY2024 Oct 31, 2023 $152.00M Dec 19, 2024
FY2023 Oct 31, 2022 $140.40M Dec 21, 2023
FY2022 Oct 31, 2021 $163.90M Dec 22, 2022
FY2021 Oct 31, 2020 $174.10M Dec 22, 2021

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Oct 31, 2025 0 Dec 18, 2025
FY2025 Oct 31, 2024 0 Dec 18, 2025
FY2025 Oct 31, 2023 0 Dec 18, 2025
FY2024 Oct 31, 2022 0 Dec 19, 2024
FY2023 Oct 31, 2021 0 Dec 21, 2023
FY2022 Oct 31, 2020 0 Dec 22, 2022
FY2021 Oct 31, 2019 1 Dec 22, 2021

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Oct 31, 2025 0 Dec 18, 2025
FY2025 Oct 31, 2024 0 Dec 18, 2025
FY2025 Oct 31, 2023 0 Dec 18, 2025
FY2024 Oct 31, 2022 0 Dec 19, 2024
FY2023 Oct 31, 2021 0 Dec 21, 2023
FY2022 Oct 31, 2020 0 Dec 22, 2022
FY2021 Oct 31, 2019 1 Dec 22, 2021

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Oct 31, 2025 70.57M Dec 18, 2025
FY2025 Oct 31, 2024 70.91M Dec 18, 2025
FY2024 Oct 31, 2023 70.73M Dec 19, 2024
FY2023 Oct 31, 2022 70.67M Dec 21, 2023
FY2022 Oct 31, 2021 70.63M Dec 22, 2022
FY2021 Oct 31, 2020 70.55M Dec 22, 2021

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2022 Oct 31, 2022 $0 Dec 22, 2022
FY2022 Oct 31, 2021 $0 Dec 22, 2022
FY2022 Oct 31, 2020 $13.00M Dec 22, 2022
FY2021 Oct 31, 2019 $5.60M Dec 22, 2021